Page 139 - product-manual
P. 139

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                                 Punica granatum (Pomegranate)

                                 Cortex et Pericarpium Punicae Granati are documented in pharmacopoeias and well established
                                 documents for their use in the treatment of intestinal parasites (WHO, 2009). Cortex Punicae
                                 Granati has properties and actions similar to those of Pericarpium Punicae Granati. Cortex
                                 Punicae Granati is used orally for the treatment of intestinal parasites such as tapeworms and
                                 roundworms (Bensky & Gamble, 1993). Pelletierine, an alkaloid constituent of Cortex Punicae
                                 Granati  has  been  found  to  be  active  against  tapeworms.  At  a  concentration  of  1:10  000,
                                 pelletierine hydrochloride exerts taenicidal effect within 5-10 minutes. This alkaloid acts by
                                 causing the tapeworm to relax its grip on the intestinal walls and thereby making it possible
                                 to be expelled by cathartics (Bensky & Gamble, 1993; Iwu, 1993). Aqueous extract of
                                 Pericarpium Punicae Granati weakly inhibited the growth of Ascaris galli,  Ascaris lumbricoides,
                                 Pheretima posthuma, and Taenia solium (Hukkeri et al., 1993; Raj, 1975).





                 Toxicity for Cortex et Pericarpium Punicae Granati has not been documented in dogs and cats when administered
                 orally in therapeutic doses.

                 The intraperitoneal LD  of Pericarpium Punicae Granati extract was found to be 1,321 ± 15 mg/kg of body
                                     50
                 weight in mice (Qnais EY et al., 2007). The LD  of Fructus Punica Granati extract, determined in mice of
                                                           50
                 both sexes after intraperitoneal administration was 731 mg/kg of body weight (Vidal et al., 2003). Acute and
                 subchronic  toxicity  of  Fructus  Punica  Granati  standardized  extract  containing  30% punicalagins,  acute  oral
            TOXICOLOGY  (NOAEL) was determined as 600 mg/kg (Patel et al. 2008).
                 LD  in rats and mice was >5,000 mg/kg of body weight, and the subchronic no-observed-adverse-effect level
                    50

                 In  animal  experiments,  intragastric  administration  of  very  large  doses  of  the  alkaloids  isolated  from  Cortex
                 Punicae Granati caused respiratory arrest and death (Bensky & Gamble, 1993). Ingestion by humans of more than
                 80 g of Cortex Punicae Granati may cause severe vomiting with blood, dizziness, fever, tremor, and collapse.
                 After 10 hours to 3 days temporary blindness may occur, this usually resolves after several weeks (WHO, 2009).


                 Equivalent toxic dose in 20 kg dog:   26,420 mg IP of Pericarpium Punicae Granati extract.
                 Equivalent toxic dose in 5 kg cat:    6,605 mg IP of Pericarpium Punicae Granati extract.






                         DRUG     Validated  interactions studies do not exist for Cortex et Pericarpium Punicae Granati
                INTERACTIONS      preparations. Clinical interactions with other drugs have not been reported.














        6  |   Pelcid-VM TM
   134   135   136   137   138   139   140   141   142   143   144